|
Canada-0-REFLEXOLOGISTS Azienda Directories
|
Azienda News:
- Whole-Genome Phylogenetic Analysis of Influenza B Phuket 3073 . . . - PubMed
Based on hemagglutinin (HA) and neuraminidase (NA) genes, recent surveillance study has identified reassortment properties in B Phuket 3073 2013-like virus, which is currently used in the WHO-recommended influenza vaccine
- (PDF) Whole-Genome Phylogenetic Analysis of Influenza B Phuket 3073 . . .
Based on hemagglutinin (HA) and neuraminidase (NA) genes, recent surveillance study has identified reassortment properties in B Phuket 3073 2013-like virus, which is currently used in the
- B Phuket 3073 2013-Like Virus (B Singapore Inftt-16-0610 2016, Wild . . .
Este artículo trata sobre ensayos clínicos que involucran el uso del Virus B Phuket 3073 2013-Like (B Singapore INFTT-16-0610 2016, Tipo Salvaje) como componente en vacunas contra la influenza
- Influenza B virus B Phuket 3073 2013 live (attenuated) antigen
Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques
- INFLUENZA B VIRUS B PHUKET 3073 2013 BVR-1B WHOLE
FDA's Global Substance Registration System enables efficient and accurate exchange of information on substances through their Unique Ingredient Identifiers (UNIIs)
- Influenza B Yamagata lineage egg-derived1 candidate vaccine viruses for . . .
Antigenic and genetic analyses are performed by the WHO Collaborating Centres of the Global Influenza Surveillance and Response System (GISRS) Unless otherwise specified, all candidate vaccine viruses posted on this table have passed two-way haemagglutination inhibition (HI) test
- Influenza Virus Infectious B Phuket 3073 2013 (B-Yamagata lineage) - NIBSC
Reagent 21 132 is prepared from B Phuket 3073 2013 (B-Yamagata lineage), which was processed in 250μl volumes as liquid stock The derivation and known passage history of 21 132 is attached
- In Vitro Properties and Virulence of Contemporary Recombinant Influenza . . .
As the original B Phuket 3073 2013 vaccine strain was passaged in embryonated eggs, we identified in its HA protein the N196D egg-adapted substitution that could potentially increase viral pathogenicity in mice through adaptation to a α2,3 sialic acid receptor
- B Phuket 3073 2013-Like Virus (B Phuket 3073 2013, Wild Type)
B Phuket 3073 2013-Like Virus is a strain of influenza B virus used in many seasonal flu vaccines It belongs to the B Yamagata lineage and is included to provide protection against this specific type of influenza B virus
- Figure 1 from Whole-Genome Phylogenetic Analysis of Influenza B Phuket . . .
Molecular properties and evolution dynamics of influenza B viruses circulating in Germany between 1996 and 2020 are investigated and the interplay between substitutions in the glycosylation sites and RBS and antigenic epitope during HA evolution is highlighted
|
|